arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Merck & Co., Inc.

MRK
$128.34 0.00 (0.00%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
74 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Bullish
auto_awesome

Analytical Summary

Merck & Co., Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $317.3B
Dividend Yield 0.66%
Revenue Growth 4.9%
Op. Margin
ROIC
FCF / Share $1.18
Trailing P/E
Price / Book 6.9x
FCF Yield 0.9%
Debt / Equity 1.02
info Valuation on last close. End-of-day price, Aug 6, 2026.

74-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$16.29B
↑ +4.9%
Net Income Profit after all expenses
$-4.24B
↓ -243.1%
FCF / Share Free cash flow per share
$1.18
↑ +154.9%
Long-Term Debt Long-term obligations
$46.67B
— -0.2%
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
85
Returns
94
Financial Health
32
Cash Quality
47

Dividend History

Dividend / share · sourced from SEC filings
$3.28 Latest / share
+5.1% YoY
+5.8% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters